SCHEMBL3368574

SCHEMBL3368574

Bc1cc([N+](=O)[O-])cnc1OC

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
PKM P14618 1/20 0.40
ALDH1A1 P00352 2/20 0.40
KAT2B Q92831 1/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 2/20 0.38
PABPC1 P11940 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29865611 0.81 HTT (0.50) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL9178607 0.81 ALDH1A1 (0.46) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL30390090 0.81 ALDH1A1 (0.46) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL2207311 0.81 HTT (0.50) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL1559460 0.81 ALDH1A1 (0.44) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL3357119 0.79 ALDH1A1 (0.46) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL30543269 0.79 MAPT (0.40) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL116509 0.79 MAPT (0.40) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL14988555 0.79 KMT2A (0.47) MAPTPKMALDH1A1KAT2BNPC1
SCHEMBL3318266 0.79 CTSV (0.48) MAPTPKMALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012002577-A1 NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF 富士フイルム株式会社 (JP) 2012-01-05 WO disclosed
WO-2011053697-A1 2-AMINOINDOLE COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA GENZYME CORPORATION (US) 2011-05-05 WO disclosed